Hashimoto's myoclonic encephalopathy: An underdiagnosed treatable condition?

We report two patients with subacute diffuse encephalopathy characterized by confusion, myoclonic encephalopathy, and mild akineto‐rigid extrapyramidal signs in one case and by apathy, memory deficit, and partial complex seizures in the other. Hashimoto's thyroiditis with high titers of antithy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Movement disorders 1996-09, Vol.11 (5), p.555-562
Hauptverfasser: Ghika-Schmid, F., Ghika, J., Regli, F., Dworak, N., Bogousslavsky, J., Städler, C., Portmann, L., Despland, P. A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 562
container_issue 5
container_start_page 555
container_title Movement disorders
container_volume 11
creator Ghika-Schmid, F.
Ghika, J.
Regli, F.
Dworak, N.
Bogousslavsky, J.
Städler, C.
Portmann, L.
Despland, P. A.
description We report two patients with subacute diffuse encephalopathy characterized by confusion, myoclonic encephalopathy, and mild akineto‐rigid extrapyramidal signs in one case and by apathy, memory deficit, and partial complex seizures in the other. Hashimoto's thyroiditis with high titers of antithyroglobulin antibodies was diagnosed in both patients, who were unresponsive to anticonvulsant medication, but showed rapid neurological improvement following steroid treatment. On neuropsychological examination, predominant frontotemporal dysfunction was noted. Electroencephalographic activity was remarkable for its rhythmical delta activity, unresponsive to, or even paradoxically increased by, anticonvulsant treatment. On magnetic resonance imaging, atrophy with temporal predominance was found. These observations support the idea that this potentially treatable dementia and movement disorder should be classified as a separate clinical entity.
doi_str_mv 10.1002/mds.870110511
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78451029</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78451029</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4691-a39f8310963b3eefde50f7a3f39ab216c72f37c4b1afa047342a82546a747a3e3</originalsourceid><addsrcrecordid>eNp90MFu1DAQBmALgcpSOHJEygHBKcUTJ7bDpapaaBELHCjq0Zo4Y9aQ2IudFezbk2qjFSckSz7M5_HMz9hz4GfAefVm7POZVhyANwAP2AoaAaWuGvWQrbjWTSlAN4_Zk5x_8Fk1IE_YidZS1q1asfUN5o0f4xRf52LcRzvE4G1BwdJ2g0Pc4rTZvy0uQrELPaXe4_cQM_XFlAgn7AYqbAy9n3wM50_ZI4dDpmfLfcq-vX93e3lTrr9cf7i8WJe2li2UKFqnBfBWik4QuZ4a7hQKJ1rsKpBWVU4oW3eADnmtRF3hvFAtUdUzI3HKXh36blP8taM8mdFnS8OAgeIuG6XrBnjVzrA8QJtizomc2SY_Ytob4OY-PTOnZ47pzf7F0njXjdQf9RLXXH-51DFbHFzCYH0-MlHx-dwzdWC__UD7__9pPl19_XeAZWCfJ_pzfInpp5FKqMbcfb42a5C3oK7uzEfxF1CDlug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78451029</pqid></control><display><type>article</type><title>Hashimoto's myoclonic encephalopathy: An underdiagnosed treatable condition?</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Ghika-Schmid, F. ; Ghika, J. ; Regli, F. ; Dworak, N. ; Bogousslavsky, J. ; Städler, C. ; Portmann, L. ; Despland, P. A.</creator><creatorcontrib>Ghika-Schmid, F. ; Ghika, J. ; Regli, F. ; Dworak, N. ; Bogousslavsky, J. ; Städler, C. ; Portmann, L. ; Despland, P. A.</creatorcontrib><description>We report two patients with subacute diffuse encephalopathy characterized by confusion, myoclonic encephalopathy, and mild akineto‐rigid extrapyramidal signs in one case and by apathy, memory deficit, and partial complex seizures in the other. Hashimoto's thyroiditis with high titers of antithyroglobulin antibodies was diagnosed in both patients, who were unresponsive to anticonvulsant medication, but showed rapid neurological improvement following steroid treatment. On neuropsychological examination, predominant frontotemporal dysfunction was noted. Electroencephalographic activity was remarkable for its rhythmical delta activity, unresponsive to, or even paradoxically increased by, anticonvulsant treatment. On magnetic resonance imaging, atrophy with temporal predominance was found. These observations support the idea that this potentially treatable dementia and movement disorder should be classified as a separate clinical entity.</description><identifier>ISSN: 0885-3185</identifier><identifier>EISSN: 1531-8257</identifier><identifier>DOI: 10.1002/mds.870110511</identifier><identifier>PMID: 8866497</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Aged ; Anti-Inflammatory Agents - administration &amp; dosage ; Anti-Inflammatory Agents - therapeutic use ; Anticonvulsants - administration &amp; dosage ; Anticonvulsants - therapeutic use ; Biological and medical sciences ; Brain - physiopathology ; Clonazepam - administration &amp; dosage ; Clonazepam - therapeutic use ; Cognition Disorders - diagnosis ; Electroencephalography ; Extrapyramidal Tracts - physiopathology ; Female ; Frontal Lobe - physiopathology ; Hashimoto's myoclonic encephalopathy ; Humans ; Medical sciences ; Methylprednisolone - administration &amp; dosage ; Methylprednisolone - therapeutic use ; Myoclonus - drug therapy ; Myoclonus - physiopathology ; Nervous system involvement in other diseases. Miscellaneous ; Neurology ; Neuropsychological Tests ; Prednisone - administration &amp; dosage ; Prednisone - therapeutic use ; Subacute diffuse encephalopathy ; Temporal Lobe - physiopathology ; Thyroiditis ; Thyroiditis, Autoimmune - diagnosis ; Thyroiditis, Autoimmune - drug therapy ; Thyroiditis, Autoimmune - physiopathology ; Thyrotropin - secretion</subject><ispartof>Movement disorders, 1996-09, Vol.11 (5), p.555-562</ispartof><rights>Copyright © 1996 Movement Disorder Society</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4691-a39f8310963b3eefde50f7a3f39ab216c72f37c4b1afa047342a82546a747a3e3</citedby><cites>FETCH-LOGICAL-c4691-a39f8310963b3eefde50f7a3f39ab216c72f37c4b1afa047342a82546a747a3e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fmds.870110511$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fmds.870110511$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,1411,23909,23910,25118,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3203207$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8866497$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ghika-Schmid, F.</creatorcontrib><creatorcontrib>Ghika, J.</creatorcontrib><creatorcontrib>Regli, F.</creatorcontrib><creatorcontrib>Dworak, N.</creatorcontrib><creatorcontrib>Bogousslavsky, J.</creatorcontrib><creatorcontrib>Städler, C.</creatorcontrib><creatorcontrib>Portmann, L.</creatorcontrib><creatorcontrib>Despland, P. A.</creatorcontrib><title>Hashimoto's myoclonic encephalopathy: An underdiagnosed treatable condition?</title><title>Movement disorders</title><addtitle>Mov. Disord</addtitle><description>We report two patients with subacute diffuse encephalopathy characterized by confusion, myoclonic encephalopathy, and mild akineto‐rigid extrapyramidal signs in one case and by apathy, memory deficit, and partial complex seizures in the other. Hashimoto's thyroiditis with high titers of antithyroglobulin antibodies was diagnosed in both patients, who were unresponsive to anticonvulsant medication, but showed rapid neurological improvement following steroid treatment. On neuropsychological examination, predominant frontotemporal dysfunction was noted. Electroencephalographic activity was remarkable for its rhythmical delta activity, unresponsive to, or even paradoxically increased by, anticonvulsant treatment. On magnetic resonance imaging, atrophy with temporal predominance was found. These observations support the idea that this potentially treatable dementia and movement disorder should be classified as a separate clinical entity.</description><subject>Adult</subject><subject>Aged</subject><subject>Anti-Inflammatory Agents - administration &amp; dosage</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Anticonvulsants - administration &amp; dosage</subject><subject>Anticonvulsants - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Brain - physiopathology</subject><subject>Clonazepam - administration &amp; dosage</subject><subject>Clonazepam - therapeutic use</subject><subject>Cognition Disorders - diagnosis</subject><subject>Electroencephalography</subject><subject>Extrapyramidal Tracts - physiopathology</subject><subject>Female</subject><subject>Frontal Lobe - physiopathology</subject><subject>Hashimoto's myoclonic encephalopathy</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Methylprednisolone - administration &amp; dosage</subject><subject>Methylprednisolone - therapeutic use</subject><subject>Myoclonus - drug therapy</subject><subject>Myoclonus - physiopathology</subject><subject>Nervous system involvement in other diseases. Miscellaneous</subject><subject>Neurology</subject><subject>Neuropsychological Tests</subject><subject>Prednisone - administration &amp; dosage</subject><subject>Prednisone - therapeutic use</subject><subject>Subacute diffuse encephalopathy</subject><subject>Temporal Lobe - physiopathology</subject><subject>Thyroiditis</subject><subject>Thyroiditis, Autoimmune - diagnosis</subject><subject>Thyroiditis, Autoimmune - drug therapy</subject><subject>Thyroiditis, Autoimmune - physiopathology</subject><subject>Thyrotropin - secretion</subject><issn>0885-3185</issn><issn>1531-8257</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90MFu1DAQBmALgcpSOHJEygHBKcUTJ7bDpapaaBELHCjq0Zo4Y9aQ2IudFezbk2qjFSckSz7M5_HMz9hz4GfAefVm7POZVhyANwAP2AoaAaWuGvWQrbjWTSlAN4_Zk5x_8Fk1IE_YidZS1q1asfUN5o0f4xRf52LcRzvE4G1BwdJ2g0Pc4rTZvy0uQrELPaXe4_cQM_XFlAgn7AYqbAy9n3wM50_ZI4dDpmfLfcq-vX93e3lTrr9cf7i8WJe2li2UKFqnBfBWik4QuZ4a7hQKJ1rsKpBWVU4oW3eADnmtRF3hvFAtUdUzI3HKXh36blP8taM8mdFnS8OAgeIuG6XrBnjVzrA8QJtizomc2SY_Ytob4OY-PTOnZ47pzf7F0njXjdQf9RLXXH-51DFbHFzCYH0-MlHx-dwzdWC__UD7__9pPl19_XeAZWCfJ_pzfInpp5FKqMbcfb42a5C3oK7uzEfxF1CDlug</recordid><startdate>199609</startdate><enddate>199609</enddate><creator>Ghika-Schmid, F.</creator><creator>Ghika, J.</creator><creator>Regli, F.</creator><creator>Dworak, N.</creator><creator>Bogousslavsky, J.</creator><creator>Städler, C.</creator><creator>Portmann, L.</creator><creator>Despland, P. A.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>8BM</scope></search><sort><creationdate>199609</creationdate><title>Hashimoto's myoclonic encephalopathy: An underdiagnosed treatable condition?</title><author>Ghika-Schmid, F. ; Ghika, J. ; Regli, F. ; Dworak, N. ; Bogousslavsky, J. ; Städler, C. ; Portmann, L. ; Despland, P. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4691-a39f8310963b3eefde50f7a3f39ab216c72f37c4b1afa047342a82546a747a3e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anti-Inflammatory Agents - administration &amp; dosage</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Anticonvulsants - administration &amp; dosage</topic><topic>Anticonvulsants - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Brain - physiopathology</topic><topic>Clonazepam - administration &amp; dosage</topic><topic>Clonazepam - therapeutic use</topic><topic>Cognition Disorders - diagnosis</topic><topic>Electroencephalography</topic><topic>Extrapyramidal Tracts - physiopathology</topic><topic>Female</topic><topic>Frontal Lobe - physiopathology</topic><topic>Hashimoto's myoclonic encephalopathy</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Methylprednisolone - administration &amp; dosage</topic><topic>Methylprednisolone - therapeutic use</topic><topic>Myoclonus - drug therapy</topic><topic>Myoclonus - physiopathology</topic><topic>Nervous system involvement in other diseases. Miscellaneous</topic><topic>Neurology</topic><topic>Neuropsychological Tests</topic><topic>Prednisone - administration &amp; dosage</topic><topic>Prednisone - therapeutic use</topic><topic>Subacute diffuse encephalopathy</topic><topic>Temporal Lobe - physiopathology</topic><topic>Thyroiditis</topic><topic>Thyroiditis, Autoimmune - diagnosis</topic><topic>Thyroiditis, Autoimmune - drug therapy</topic><topic>Thyroiditis, Autoimmune - physiopathology</topic><topic>Thyrotropin - secretion</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ghika-Schmid, F.</creatorcontrib><creatorcontrib>Ghika, J.</creatorcontrib><creatorcontrib>Regli, F.</creatorcontrib><creatorcontrib>Dworak, N.</creatorcontrib><creatorcontrib>Bogousslavsky, J.</creatorcontrib><creatorcontrib>Städler, C.</creatorcontrib><creatorcontrib>Portmann, L.</creatorcontrib><creatorcontrib>Despland, P. A.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>ComDisDome</collection><jtitle>Movement disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ghika-Schmid, F.</au><au>Ghika, J.</au><au>Regli, F.</au><au>Dworak, N.</au><au>Bogousslavsky, J.</au><au>Städler, C.</au><au>Portmann, L.</au><au>Despland, P. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hashimoto's myoclonic encephalopathy: An underdiagnosed treatable condition?</atitle><jtitle>Movement disorders</jtitle><addtitle>Mov. Disord</addtitle><date>1996-09</date><risdate>1996</risdate><volume>11</volume><issue>5</issue><spage>555</spage><epage>562</epage><pages>555-562</pages><issn>0885-3185</issn><eissn>1531-8257</eissn><abstract>We report two patients with subacute diffuse encephalopathy characterized by confusion, myoclonic encephalopathy, and mild akineto‐rigid extrapyramidal signs in one case and by apathy, memory deficit, and partial complex seizures in the other. Hashimoto's thyroiditis with high titers of antithyroglobulin antibodies was diagnosed in both patients, who were unresponsive to anticonvulsant medication, but showed rapid neurological improvement following steroid treatment. On neuropsychological examination, predominant frontotemporal dysfunction was noted. Electroencephalographic activity was remarkable for its rhythmical delta activity, unresponsive to, or even paradoxically increased by, anticonvulsant treatment. On magnetic resonance imaging, atrophy with temporal predominance was found. These observations support the idea that this potentially treatable dementia and movement disorder should be classified as a separate clinical entity.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>8866497</pmid><doi>10.1002/mds.870110511</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0885-3185
ispartof Movement disorders, 1996-09, Vol.11 (5), p.555-562
issn 0885-3185
1531-8257
language eng
recordid cdi_proquest_miscellaneous_78451029
source MEDLINE; Wiley Online Library All Journals
subjects Adult
Aged
Anti-Inflammatory Agents - administration & dosage
Anti-Inflammatory Agents - therapeutic use
Anticonvulsants - administration & dosage
Anticonvulsants - therapeutic use
Biological and medical sciences
Brain - physiopathology
Clonazepam - administration & dosage
Clonazepam - therapeutic use
Cognition Disorders - diagnosis
Electroencephalography
Extrapyramidal Tracts - physiopathology
Female
Frontal Lobe - physiopathology
Hashimoto's myoclonic encephalopathy
Humans
Medical sciences
Methylprednisolone - administration & dosage
Methylprednisolone - therapeutic use
Myoclonus - drug therapy
Myoclonus - physiopathology
Nervous system involvement in other diseases. Miscellaneous
Neurology
Neuropsychological Tests
Prednisone - administration & dosage
Prednisone - therapeutic use
Subacute diffuse encephalopathy
Temporal Lobe - physiopathology
Thyroiditis
Thyroiditis, Autoimmune - diagnosis
Thyroiditis, Autoimmune - drug therapy
Thyroiditis, Autoimmune - physiopathology
Thyrotropin - secretion
title Hashimoto's myoclonic encephalopathy: An underdiagnosed treatable condition?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T11%3A13%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hashimoto's%20myoclonic%20encephalopathy:%20An%20underdiagnosed%20treatable%20condition?&rft.jtitle=Movement%20disorders&rft.au=Ghika-Schmid,%20F.&rft.date=1996-09&rft.volume=11&rft.issue=5&rft.spage=555&rft.epage=562&rft.pages=555-562&rft.issn=0885-3185&rft.eissn=1531-8257&rft_id=info:doi/10.1002/mds.870110511&rft_dat=%3Cproquest_cross%3E78451029%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78451029&rft_id=info:pmid/8866497&rfr_iscdi=true